These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 25658633)

  • 1. Clinical and neuroimaging biomarkers of amyloid-negative logopenic primary progressive aphasia.
    Whitwell JL; Duffy JR; Strand EA; Machulda MM; Senjem ML; Schwarz CG; Reid R; Baker MC; Perkerson RB; Lowe VJ; Rademakers R; Jack CR; Josephs KA
    Brain Lang; 2015 Mar; 142():45-53. PubMed ID: 25658633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progranulin-associated PiB-negative logopenic primary progressive aphasia.
    Josephs KA; Duffy JR; Strand EA; Machulda MM; Vemuri P; Senjem ML; Perkerson RB; Baker MC; Lowe V; Jack CR; Rademakers R; Whitwell JL
    J Neurol; 2014 Mar; 261(3):604-14. PubMed ID: 24449064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated occipital β-amyloid deposition is associated with widespread cognitive impairment in logopenic progressive aphasia.
    Whitwell JL; Lowe VJ; Duffy JR; Strand EA; Machulda MM; Kantarci K; Wille SM; Senjem ML; Murphy MC; Gunter JL; Jack CR; Josephs KA
    J Neurol Neurosurg Psychiatry; 2013 Dec; 84(12):1357-64. PubMed ID: 23946416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDG PET and MRI in logopenic primary progressive aphasia versus dementia of the Alzheimer's type.
    Madhavan A; Whitwell JL; Weigand SD; Duffy JR; Strand EA; Machulda MM; Tosakulwong N; Senjem ML; Gunter JL; Lowe VJ; Petersen RC; Jack CR; Josephs KA
    PLoS One; 2013; 8(4):e62471. PubMed ID: 23626825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varying Degrees of Temporoparietal Hypometabolism on FDG-PET Reveal Amyloid-Positive Logopenic Primary Progressive Aphasia is not a Homogeneous Clinical Entity.
    Krishnan K; Machulda MM; Whitwell JL; Butts AM; Duffy JR; Strand EA; Senjem ML; Spychalla AJ; Jack CR; Lowe VJ; Josephs KA
    J Alzheimers Dis; 2017; 55(3):1019-1029. PubMed ID: 27802232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneous Language Profiles in Patients with Primary Progressive Aphasia due to Alzheimer's Disease.
    Louwersheimer E; Keulen MA; Steenwijk MD; Wattjes MP; Jiskoot LC; Vrenken H; Teunissen CE; van Berckel BN; van der Flier WM; Scheltens P; van Swieten JC; Pijnenburg YA
    J Alzheimers Dis; 2016; 51(2):581-90. PubMed ID: 26890751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease.
    Lehmann M; Ghosh PM; Madison C; Laforce R; Corbetta-Rastelli C; Weiner MW; Greicius MD; Seeley WW; Gorno-Tempini ML; Rosen HJ; Miller BL; Jagust WJ; Rabinovici GD
    Brain; 2013 Mar; 136(Pt 3):844-58. PubMed ID: 23358601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia.
    Rabinovici GD; Jagust WJ; Furst AJ; Ogar JM; Racine CA; Mormino EC; O'Neil JP; Lal RA; Dronkers NF; Miller BL; Gorno-Tempini ML
    Ann Neurol; 2008 Oct; 64(4):388-401. PubMed ID: 18991338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual cognition in non-amnestic Alzheimer's disease: Relations to tau, amyloid, and cortical atrophy.
    Putcha D; Brickhouse M; Touroutoglou A; Collins JA; Quimby M; Wong B; Eldaief M; Schultz A; El Fakhri G; Johnson K; Dickerson BC; McGinnis SM
    Neuroimage Clin; 2019; 23():101889. PubMed ID: 31200149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF levels of Aβ1-38/Aβ1-40/Aβ1-42 and (11)C PiB-PET studies in three clinical variants of primary progressive aphasia and Alzheimer's disease.
    Ikeda M; Tashiro Y; Takai E; Kurose S; Fugami N; Tsuda K; Arisaka Y; Kodaira S; Fujita Y; Makioka K; Mizuno Y; Shimada H; Harigaya Y; Takatama M; Amari M; Yamazaki T; Yamaguchi H; Higuchi T; Okamoto K; Tsushima Y; Ikeda Y
    Amyloid; 2014 Dec; 21(4):238-45. PubMed ID: 25139672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlates of anomia in non-semantic variants of primary progressive aphasia converge over time.
    Leyton CE; Landin-Romero R; Liang CT; Burrell JR; Kumfor F; Hodges JR; Piguet O
    Cortex; 2019 Nov; 120():201-211. PubMed ID: 31325799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of logopenic primary progressive aphasia with C9ORF72 expansion and cortical florbetapir binding.
    Saint-Aubert L; Sagot C; Wallon D; Hannequin D; Payoux P; Nemmi F; Bezy C; Chauveau N; Campion D; Puel M; Chollet F; Pariente J
    J Alzheimers Dis; 2014; 42(2):413-20. PubMed ID: 24898647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid and FDG-PET study of logopenic primary progressive aphasia: evidence for the existence of two subtypes.
    Matías-Guiu JA; Cabrera-Martín MN; Moreno-Ramos T; Valles-Salgado M; Fernandez-Matarrubia M; Carreras JL; Matías-Guiu J
    J Neurol; 2015 Jun; 262(6):1463-72. PubMed ID: 25860346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Working memory and language network dysfunctions in logopenic aphasia: a task-free fMRI comparison with Alzheimer's dementia.
    Whitwell JL; Jones DT; Duffy JR; Strand EA; Machulda MM; Przybelski SA; Vemuri P; Gregg BE; Gunter JL; Senjem ML; Petersen RC; Jack CR; Josephs KA
    Neurobiol Aging; 2015 Mar; 36(3):1245-52. PubMed ID: 25592958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetries of amyloid-β burden and neuronal dysfunction are positively correlated in Alzheimer's disease.
    Frings L; Hellwig S; Spehl TS; Bormann T; Buchert R; Vach W; Minkova L; Heimbach B; Klöppel S; Meyer PT
    Brain; 2015 Oct; 138(Pt 10):3089-99. PubMed ID: 26280595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative assessment of grammar in amyloid-negative logopenic aphasia.
    Tetzloff KA; Whitwell JL; Utianski RL; Duffy JR; Clark HM; Machulda MM; Strand EA; Josephs KA
    Brain Lang; 2018 Nov; 186():26-31. PubMed ID: 30205287
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Cho H; Kim HJ; Choi JY; Ryu YH; Lee MS; Na DL; Seo SW; Lyoo CH
    Neurobiol Aging; 2019 Mar; 75():187-197. PubMed ID: 30594046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicoradiological and neuropathological evaluation of primary progressive aphasia.
    Shir D; Corriveau-Lecavalier N; Bermudez Noguera C; Barnard L; Pham NTT; Botha H; Duffy JR; Clark HM; Utianski RL; Knopman DS; Petersen RC; Boeve BF; Murray ME; Nguyen AT; Reichard RR; Dickson DW; Day GS; Kremers WK; Graff-Radford NR; Jones DT; Machulda MM; Fields JA; Whitwell JL; Josephs KA; Graff-Radford J
    J Neurol Neurosurg Psychiatry; 2024 Aug; 95(9):812-821. PubMed ID: 38514176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal anatomic, functional, and molecular characterization of Pick disease phenotypes.
    Whitwell JL; Tosakulwong N; Schwarz CC; Senjem ML; Spychalla AJ; Duffy JR; Graff-Radford J; Machulda MM; Boeve BF; Knopman DS; Petersen RC; Lowe VJ; Jack CR; Dickson DW; Parisi JE; Josephs KA
    Neurology; 2020 Dec; 95(24):e3190-e3202. PubMed ID: 32989107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dementia with Lewy bodies presenting as Logopenic variant primary progressive Aphasia.
    Boes S; Botha H; Machulda M; Lowe V; Graff-Radford J; Whitwell JL; Utianski RL; Duffy JR; Josephs KA
    Neurocase; 2020 Oct; 26(5):259-263. PubMed ID: 32672090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.